| Purpose | Patients | Evaluations | Perceived Effectiveness |
|---|---|---|---|
| Diabetes type 1 | 45 | 7 | |
| Diabetes type 2 | 25 | 5 | |
| Cystic fibrosis-related diabetes | 3 | 0 | |
| Latent autoimmune diabetes | 1 | 0 | |
| Maturity-onset diabetes in young | 1 | 0 |
Common side effects
| Side effect | Patients | Percentage |
|---|---|---|
| Weight gain | 2 | |
| Chronic hyperglycemia | 1 | |
| Low blood sugar (hypoglycemia) | 1 |
Side effect severity
| Severity | Evaluations | Percentage |
|---|---|---|
| Severe | 0 | |
| Moderate | 0 | |
| Mild | 4 | |
| None | 8 |